Inspire (INSP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2024 Earnings Call Transcript May 7, 2024 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is $-0.33783, expectations were $-0.63. INSP isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]
Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.